-+ 0.00%
-+ 0.00%
-+ 0.00%

On March 2, 2026, MAIA Biotechnology Entered Into An Underwriting Agreement With Konik Capital Partners; To Issue 20,000,000 Shares Of Common Stock In Public Offering

Benzinga·03/04/2026 22:38:23
Listen to the news

-SEC Filing